CNC vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

CNC

37.4
AI Score
VS
CLOV Wins

CLOV

45.8
AI Score

Investment Advisor Scores

CNC

37score
Recommendation
SELL

CLOV

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNC CLOV Winner
Revenue 2.25B 154.17B CNC
Net Income 61.77M 2.56B CNC
Net Margin 2.7% 1.7% CLOV
Operating Income 61.77M 2.75B CNC
ROE 15.8% 11.5% CLOV
ROA 8.2% 3.2% CLOV
Total Assets 753.68M 79.28B CNC
Current Ratio 1.55 1.16 CLOV
Free Cash Flow 201.03M 3.72B CNC

Relative Price Performance (Last 90 Days)

CNC 1M: +1.1% · 3M: +10.7% CLOV 1M: +6.0% · 3M: +16.2%

Current Technical Phase

CNC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 55

RSI (14): 55.4 · Price: $71.27

CLOV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 59

RSI (14): 58.5 · Price: $4.96

Fundamentals Snapshot

Metric CNC CLOV
Market Cap — —
Forward P/E 12.9 27.6
Trailing P/E 24.1 488.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.5%
Gross Margin 0.1% 0.2%
Operating Margin 0.0% 0.0%
EPS 2.91 0.01
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLOV is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.